Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer
NCT00098852
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Head and Neck Cancer
Interventions
DRUG:
rosiglitazone maleate
Sponsor
University of California, San Francisco
Collaborators
[object Object]